E-LIB Suche - Ergebnisse für: Ammerlaan, Anneke C. J.

1

Inotuzumab ozogamicin combined with chemotherapy in pediatr..:

Pennesi, Edoardo ; Brivio, Erica ; Ammerlaan, Anneke C. J....
Haematologica. , 2024

Link: https://doi.org/10.3324/..

2

Population Pharmacokinetics of Inotuzumab Ozogamicin in Ped..:

Wu, Jen-Hao ; Pennesi, Edoardo ; Bautista, Francisco...
Clinical Pharmacokinetics. , 2024

Link: https://doi.org/10.1007/..

3

Inotuzumab ozogamicin as single agent in pediatric patients..:

Pennesi, Edoardo ; Michels, Naomi ; Brivio, Erica...
Leukemia. 36 (2022) 6 - p. 1516-1524 , 2022

Link: https://doi.org/10.1038/..

4

Localization of a putative low‐penetrance ependymoma suscep..:

Ammerlaan, Anneke C. J. ; de Bustos, Cecilia ; Ararou, Abdelhay...
Genes, Chromosomes and Cancer. 43 (2005) 4 - p. 329-338 , 2005

Link: https://doi.org/10.1002/..

5

Inotuzumab ozogamicin as single agent in pediatric patients..:

Pennesi, Edoardo ; Michels, Naomi ; Brivio, Erica...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162924/. , 2022

Link: http://www.ncbi.nlm.nih...

6

A phase 1 study of inotuzumab ozogamicin in pediatric relap..:

Brivio, Erica ; Locatelli, Franco ; Lopez-Yurda, Marta...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995290/. , 2021

Link: http://www.ncbi.nlm.nih...

7

A phase 1 study of inotuzumab ozogamicin in pediatric relap..:

Brivio, Erica ; Locatelli, Franco ; Lopez-Yurda, Marta...
Brivio , E , Locatelli , F , Lopez-Yurda , M , Malone , A , Díaz-de-Heredia , C , Bielorai , B , Rossig , C , van der Velden , V H J , Ammerlaan , A C J , Thano , A , van der Sluis , I M , den Boer , M L , Chen , Y , Sleight , B , Brethon , B , Nysom , K , Sramkova , L , Øra , I , Vinti , L , Chen-Santel , C & Zwaan , C M 2021 , ' A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study) ' , Blood , vol. 137 , no. 12 , pp. 1582-1590 . https://doi.org/10.1182/blood.2020007848. , 2021

Link: https://pure.eur.nl/en/p..

8

An in vitro study on the binding of Al(III) to human serum ..:

de Jong, G. ; Ammerlaan, C. C. A. ; van Noort, W. L....
Biometals. 8 (1995) 4 - p. 352-356 , 1995

Link: https://doi.org/10.1007/..

9

Book Review: A View on Terrorism, Insurance, and Tort Law, ..:

Ammerlaan, V.C.
Maastricht Journal of European and Comparative Law. 12 (2005) 2 - p. 200-213 , 2005

Link: https://doi.org/10.1177/..

10

Flavor Profiling Using Comprehensive Mass Spectrometry Anal..:

Leygeber, Simon ; Grossmann, Justus L. ; Diez-Simon, Carmen...
Metabolites. 12 (2022) 12 - p. 1194 , 2022

Link: https://doi.org/10.3390/..

11

Controlling loss of salt rejection and water flux at the yu..:

Ammerlaan, Anton C.F. ; Franklin, John C. ; Moody, Charles D.
Desalination. 96 (1994) 1-3 - p. 421-429 , 1994

Link: https://doi.org/10.1016/..

12

Seawater desalting energy requirements as a function of var..:

Ammerlaan, A.C.F.
Desalination. 40 (1982) 3 - p. 317-326 , 1982

Link: https://doi.org/10.1016/..

13

Concentration of Dilute Pulping Wastes by Reverse Osmosis a..:

Wiley, Averill J. ; Dubey, George A. ; Holderby, J. M..
Journal (Water Pollution Control Federation). 42 (1970) 8 - p. R279-R289 , 1970

Link: https://www.jstor.org/st..

14

Differentiated mouse kidney tubuloids as a novel in vitro m..:

Olde Hanhof, C. J. A. ; Dilmen, E. ; Yousef Yengej, F. A....
Frontiers in Cell and Developmental Biology. 11 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

15

Relative risk of thrombo-embolisms and major bleedings is h..:

Janssen, E. ; Ammerlaan, K.C.P.M. ; Van Rein, N....
Atherosclerosis. 331 (2021) - p. e227 , 2021

Link: https://doi.org/10.1016/..